Immunitybio shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Immunitybio
Tip: Access up to 7 years of quarterly data
All positions including Immunitybio held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunitybio by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $982k | 183k | 5.37 |
| 2023-12-31 | $918k | 183k | 5.02 |
| 2023-09-30 | $309k | 183k | 1.69 |
| 2023-06-30 | $333k | 183k | 1.82 |
| 2023-03-31 | $333k | 183k | 1.82 |
| 2022-12-31 | $746k | 147k | 5.07 |
| 2022-09-30 | $673k | 135k | 4.97 |
| 2022-06-30 | $573k | 154k | 3.72 |
| 2022-03-31 | $566k | 101k | 5.61 |
| 2021-12-31 | $613k | 101k | 6.08 |
| 2021-09-30 | $420k | 43k | 9.74 |
| 2021-06-30 | $370k | 26k | 14.28 |
| 2021-03-31 | $515k | 22k | 23.74 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas